In the vast and highly specialized biotechnology sector, where scientific innovation results in long, expensive, and often uncertain development paths, the value of enterprises does not come from current revenues, but from the quality of the research portfolio, the soundness of patents, and the likelihood of clinicalUnbiased Alpha is a Swiss Fintech startup consulting institutional investors across the globe in Quantitative Trading and Systematic Strategies. The company develops software solutions, cloud se ...

In the vast and highly specialized biotechnology sector, where scientific innovation results in long, expensive, and often uncertain development paths, the value of enterprises does not come from current revenues, but from the quality of the research portfolio, the soundness of patents, and the likelihood of clinicalUnbiased Alpha is a Swiss Fintech startup consulting institutional investors across the globe in Quantitative Trading and Systematic Strategies. The company develops software solutions, cloud se ...

In assessing the demand for digital infrastructure—the data center—forecasts abound. Indeed, the spectrum of types of data center developments is varied. Through my research, I’ll cull a few highlights of late to cut through some noise. As any firm’s leader will say: You have to identifyJennifer's areas of expertise include energy, evolving infrastructure networks, and resources issues impacting economies. She considers her investment approach eclectic, drawing from a multidisciplinary pool of work. She is ...

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: More than 80 Spanish media organizations allege that Facebook owner Meta breached EU data protection rules. A Spanish court will open a trial on Wednesday over a 550-million-euro lawsuit brought by more than 80 Spanish media organizations against Facebook owner Meta for allegedly breaching European Union data protection rules. ...

What's better than a high-yield dividend stock? It's a high-yield dividend stock on sale, and here are two!"I do not own a single security anywhere that doesn't pay a dividend, and I formed a mutual-fund company with that very simple philosophy." – Canadian entrepreneur and investor Kevin O'LearyDividend stocks are popular investing options that historically outperform non-dividend-paying stocks. They tend to offer investors a steady and transparent income stream, and are often more resilient to economic do ...

Analyst’s Disclosure:I/we have a beneficial long position in the shares of GUTS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a partic ...

Italian energy group Eni is expected to agree a final investment decision for Mozambique's second floating liquefied natural gas (LNG) platform at an event in the capital Maputo on Thursday, two sourc... ...

I retired early after 22 years in the energy industry with roles in engineering, planning, and financial analysis. I have managed my own portfolio since 1998 and have met my goal to match the S+P 500 return over the long term with lower volatility and higher income. I mostly write on positions I already hold or am considering changing. I prefer to hold positions for the long-term unless there is a compelling reason to sell. I look for investment opportunities without regard to asset class, market cap, secto ...

Euro zone inflation accelerated last month on higher services prices and a smaller decline in energy costs, likely reinforcing bets on the ECB keeping interest rates on hold for some time. ...

Roche Holding and AstraZeneca were among those companies posting increases as European pharma stocks tracked gains in the U.S. on Tuesday. ...